Listen to the Audio Recording: Click Here

View PowerPoint: Click Here

As our economy recovers from COVID-19, we are witnessing real-time change in what is expected from our IDNs. We are undergoing a transformation that includes new state and federal policies and regulations on a variety of topics including pricing and 340B. During this presentation, participants will gain insights into new innovations, technology as well emerging trends and challenges, and learn about strategies for navigating the complex regulatory environment to improve patient outcomes and achieve business success and sustainability.

Learning objectives:

1. Evaluate regulations, including 340B and the DSCSA, that will be affecting the industry and discuss their possible specific impacts.

2. Analyze and discuss an overview of pricing issues including price transparency, limiting price increases and the need to reduce overall healthcare spending.

3. Assess advances in technology, such as telemedicine and digital health tools that have already transformed the way healthcare is delivered and preview what to expect in the coming years.

4. Develop strategies for adapting to changes in the pharmacy industry including identifying opportunities to optimize revenue and manage costs in the face of evolving policies, pricing models, and technological innovations.